Squamous cell carcinoma is a type of cancer that begins in the squamous cells, which are thin, flat cells that form the surface of the skin. It is the second most common type of skin cancer and can occur in any area of the body, but is most common in parts exposed to the sun, such as the face, neck, and arms. Squamous cell carcinoma is mostly caused by long-term exposure to ultraviolet (UV) radiation. The risk of developing squamous cell carcinoma is increased in people who have fair skin, who work outdoors, or who use tanning beds. The signs and symptoms of squamous cell carcinoma include a scaly red patch, open sores, elevated growths with a central depression, and wart-like growths. Squamous cell carcinoma may also appear as a lump with a rough, scaly, or crusted surface. If left untreated, squamous cell carcinoma can spread to other areas of the body, including the lymph nodes and internal organs. In order to diagnose squamous cell carcinoma, a doctor may perform a biopsy, during which a small sample of the affected area will be taken and examined under a microscope. Treatment for squamous cell carcinoma typically involves surgery, radiation therapy, and/or topical medications. For more severe cases, chemotherapy and immunotherapy may also be used. Squamous cell carcinoma can be prevented by avoiding prolonged sun exposure, wearing protective clothing and sunscreen, and avoiding tanning beds. People should also regularly check their skin for any changes or growths and report any changes to their doctor. Early detection is key to successful treatment of squamous cell carcinoma.
Background: The miR-21 targets those genes which are associated with a metastatic process in OSCC. The aim of the study was to evaluate the diagnostic accuracy of miR-21 for the assessment of…
Introduction: The Oral Squamous Cell carcinoma (OSCC) is the most prevalent cancer in the oral cavity with the highest mortality rate. Anticancer drugs like Cisplatin are used extensively to treat…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Squamous Cell Carcinoma work, reviewed by the scientific committee.
Meet dentists, oral-health researchers, and clinical leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Squamous Cell Carcinoma research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Squamous Cell Carcinoma track is a dedicated stream within Dental 2027 covering the latest research, clinical innovation, and best practice in Squamous Cell Carcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Educators, doctoral students, and dentists, oral-health researchers, and clinical leaders with an interest in Squamous Cell Carcinoma are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. Dental 2027 is a hybrid conference — attend the Squamous Cell Carcinoma track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
Register